|
|
|
Welcome
to LymphomaLinks,
your monthly source of lymphoma news, research
updates, clinical trials and events sponsored by
The Leukemia & Lymphoma Society (LLS). For
even more information, regularly visit
LLS's Patient
Services and Disease
Information Web
sections. | |
 |
|
|
|
LLS
Features
::READ
MORE::
.....................................................................................................................................
Research
Roundup
::READ
MORE::
.....................................................................................................................................
IRC Question of
the Month
:: READ
MORE::
| |
|
|
Inspirational
Stories
 Learn how individuals touched
by blood cancer cope. LLS's LifeMosaic Web feature offers
hundreds of inspiring stories by patients and families. Read
them or submit your own. This month, meet
John of Beverly Hills,
CA. |
Here to
Help
For
even more information, regularly visit the LLS
Web site,
www.LLS.org
,
where many of our education programs are
archived free of charge for convenient access
24/7.
If you haven't found what you're
looking for in LymphomaLinks , please
call our Information Resource Center (IRC) to
speak with trained information specialists. IRC
staff are available Monday through Friday, 9
a.m. to 6 p.m. ET, toll free at (800) 955-4572;
email
infocenter@lls.org
;
or click the "Live Patient Help" button on the
www.LLS.org homepage.
| |
|
|
Commentary
LLS's Deborah Banker, Ph.D., discusses
some of the latest innovations presented at the
recent American Society of Hematology annual
meeting.
Clinical
Trials
We
invite you to use
our LLS-supported TrialCheck®
Web site, a clinical trial search service
that offers patients and caregivers immediate
access to listings of
all lymphoma clinical trials. Answer
just a few simple questions and a list of
available clinical trials related to your cancer
will appear in an easy to read list of search
results.
You may also want to visit the
National Cancer Institute's Cancer
Trials Support Unit, providing resources and
information on phase III cancer treatment trials
supported by the National Cancer
Institute
. ::SELECTED TRIALS::
Newsfeeds &
Podcasts
Now you can get
RSS Feeds and Podcasts from LLS.
::CLICK HERE TO SIGN
UP::
Free
eNewsletters
Free LLS
eNewsletters deliver the latest information on
research and treatment options, patient services
programs and fundraising events.
:: CLICK HERE TO SIGN
UP::
| | | |
| 
| | | |
|
|
|
Long-term progression-free survival after
early autologous transplantation for mantle cell
lymphoma ::READ MORE::
Hematopoietic SCT for peripheral T-cell
lymphoma ::READ MORE::
A multicenter Phase II study of
risk-adjusted salvage chemotherapy incorporating
vinorelbine and gemcitabine for relapsed and
refractory lymphoma
::READ MORE::
Long term survival in Waldenstrom
macroglobulinemia: 10-year follow-up of
Southwest Oncology Group (SWOG) directed
intergroup trial S9003 ::READ
MORE::
Allogeneic hematopoietic cell transplantation
for Hodgkin lymphoma: a concise review
::READ MORE::
>Back to the
top
| |
Selected
Trials
A Phase I-II Multicenter,
Open-Label Study of AEG35156 in Patients with
Relapsed or Refractory Indolent B-Cell
Lymphomas and Chronic Lymphocytic
Leukemia ::READ MORE::
Pilot Trial of Intravenous
Vitamin C in Refractory Non-Hodgkin
Lymphoma ::READ MORE::
A Randomized Phase IIb
Placebo-Controlled Study of R-ICE Chemotherapy
with and without SGN-40 for Patients with
DLBCL ::READ MORE::
Safety and Efficacy of RAD001 in
Patients with Velcade Refractory Mantle Cell
Lymphoma ::READ MORE::
Study of Oral LBH589 in Adult
Patients with Refractory Cutaneous T-Cell
Lymphoma ::READ MORE::
Bortezomib, Ifosfamide,
Carboplatin and Etoposide, with or without
Rituximab, in Treating Patients with Relapsed or
Refractory AIDS-Related Non-Hodgkin
Lymphoma ::READ MORE::
> Back to the
top
| |
| IRC
Question of
the Month | 
Q: At what age is a patient
not eligible for a clinical trial?
A: All clinical trials have
eligibility guidelines. These guidelines may be
based on the patient's age, the type and stage
of disease, previous treatment history and any
co-existing medical conditions; for example,
diabetes or high blood pressure.
Guidelines are sometimes called "inclusion
criteria" (the characteristics of patients who
may take part in the trial) and "exclusion
criteria" (the characteristics of patients who
cannot take part in the trial). Inclusion and
exclusion criteria are used to ensure that
patient participation is appropriate for the
goals of the trial and to produce reliable
medical research results.
Some older patients may assume clinical
trials are not for them. This is not necessarily
true. Studies have shown that age alone does not
reflect a person's overall health and ability to
benefit from a clinical trial. Many older adults
have been treated successfully in clinical
trials. According to reports, overall,
patients in clinical trials receive more
follow-up care and better disease and
side-effect management, compared
with patients receiving treatment outside
of clinical trial settings.
Nationwide participation in clinical trials
by older adults is growing. Participation
across age-groups helps doctors determine if a
treatment is safe and effective for people of
different ages. Some trials are not appropriate
for older adults or a subgroup of older adults,
such as those with serious medical
complications. But more trials are being offered
to older adults, and there are also trials
designed specifically for them.
It is important to discuss clinical trials as
an option with your doctor. Please also
contact LLS's Information Resource
Center (IRC) at ( 800) 955-4572 to
find out more about clinical trials and other
treatment options for older adults
with lymphoma. You may also order the free
LLS booklet Understanding
Clinical Trials for Blood Cancers
.
As
always the IRC is here to help. To speak
with an IRC specialist, Monday through
Friday, 9 a.m. to 6 p.m. ET, please
call (800) 955-4572, or visit www.LLS.org.
> Back to the
top
| |
| | | |
|
|
 |
Supported by an
unrestricted
educational grant
from
 |
 |
|
Contact Us: The
Leukemia & Lymphoma Society, 1311 Mamaroneck
Ave., White Plains, NY 10605, (800)
955-4572
|
|
| Visit our e-Store
& Special Offers page where you can
support businesses that support
LLS. | | | | | |
|
| | | |
